Homoeopathic medicines in cases of psoriasis

Study of individualized homoeopathic medicines in cases of psoriasis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/058136

Enrollment

Registered

2023-09-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L401- Generalized pustular psoriasis

Interventions

Intervention1: Individualised Homoeopathic medicine: Intervention is planned as administering indicated homoeopathic medicine according to case or condition. In this potency each dose shall consist of

Eligibility

Inclusion criteria

Inclusion criteria: Patient having clinical manifestation of psoriasis or prediagnosed with psoriasis.

Exclusion criteria

Exclusion criteria: 1.immuno compromised state 2. Patients with severe co-morbidities which require intensive care 3. Cases with irregular follow ups. 4. Cases with morbid pathological conditions

Design outcomes

Primary

Measure	Time frame
To clinically assess the individualised homoeopathic treatment outcome in psoriasis by using PASITimepoint: 12th week, 24th week	—

Secondary

Measure	Time frame
To assess the quality of life by using DLQITimepoint: 3rd Month, 6th Month	—

Countries

India

Contacts

Public ContactDr Zulekha Dalal

Jawaharlal Nehru Homoeopathic Medical College and Hospital,Parul University

kirtidadesai@paruluniversity.ac.in9574424363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026